Exploratory Study to Investigate the Reparative and Regenerative Potential of Alemtuzumab in Relapsing-Remitting Multiple Sclerosis Patients Participating in the CARE MS I and MS II Studies
This study has been completed.
Study NCT01020370
Information provided by Wayne State University
First Received on November 24, 2009.
No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
